BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6975766)

  • 1. Synthetic C3a analogs as specific inhibitors of C3a activity.
    Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
    Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active site of human C4a anaphylatoxin.
    Hugli TE; Kawahara MS; Unson CG; Molinar-Rode R; Erickson BW
    Mol Immunol; 1983 Jun; 20(6):637-45. PubMed ID: 6603573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C; Damerau B; Lemgo E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):71-6. PubMed ID: 1004644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin.
    Hugli TE; Erickson BW
    Proc Natl Acad Sci U S A; 1977 May; 74(5):1826-30. PubMed ID: 266705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
    Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
    Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.
    Meuer S; Zanker B; Hadding U; Bitter-Suermann D
    J Exp Med; 1982 Mar; 155(3):698-710. PubMed ID: 6977607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
    Becker S; Meuer S; Hadding U; Bitter-Suermann D
    Scand J Immunol; 1978; 7(2):173-80. PubMed ID: 653315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of humoral immune responses by synthetic C3a peptides.
    Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
    J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraction of guinea pig lung by synthetic oligopeptides related to human C3a.
    Huey R; Erickson BW; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Aug; 8(1):37-45. PubMed ID: 6333413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac dysfunction caused by purified human C3a anaphylatoxin.
    del Balzo UH; Levi R; Polley MJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):886-90. PubMed ID: 2579381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro.
    Marom Z; Shelhamer J; Berger M; Frank M; Kaliner M
    J Exp Med; 1985 Apr; 161(4):657-68. PubMed ID: 2580036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S; Glovsky MM; Kunkel SL
    Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.